All News about Foghorn Therapeutics Inc
Foghorn Therapeutics: Q4 Earnings Insights
March 07, 2024
Via Benzinga
What 5 Analyst Ratings Have To Say About Foghorn Therapeutics
August 07, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 08, 2024
Via Benzinga
Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor
February 08, 2024
Via GlobeNewswire
Foghorn Therapeutics Announces CFO Departure
January 03, 2024
Via GlobeNewswire
Via GlobeNewswire
Foghorn Therapeutics Announces Chief Medical Officer Succession
August 08, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.